| Market Cap | ₹34Cr |
| ROE | -13.06% |
| P/E Ratio(TTM) | -36.20 |
| EPS(TTM) | -1.27 |
| P/B Ratio | 5.57 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.62 |
| Book Value | 8.26 |
| Debt to Equity | 0.08 |
| Face Value | 10 |
| Parent Organisation | Gujarat Terce Laboratories Limited |
| Managing Director | Mr. Aalap Prajapati |
| BSE Symbol | 524314 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.51 | ||
| Ajanta Pharma | NA (0.00%) | 32.41 | ||
| Gland Pharma | NA (0.00%) | 38.79 | ||
| Eris Lifesciences | NA (0.00%) | 52.71 |